T0	Outcomes 85 124	human immunodeficiency virus infection.
T1	Outcomes 220 255	human immunodeficiency virus type 1
T2	Outcomes 1030 1050	Delavirdine exposure
T3	Outcomes 1111 1153	maximum drug concentration in serum (Cmax)
T4	Outcomes 1216 1255	area under the concentration-time curve
T5	Outcomes 1352 1376	extent of N-dealkylation
T6	Outcomes 1398 1452	ratio of the N-dealkylated delavirdine AUC0-->infinity
T7	Outcomes 1460 1487	delavirdine AUC0-->infinity
T8	Outcomes 1554 1573	didanosine exposure
T9	Outcomes 1645 1649	Cmax
T10	Outcomes 1856 1871	AUC0-->infinity